Delivery Order SPE2DR25D3401-SPE2DR26FL1CB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Qsymia 7.5 mg-46 mg capsules (30-count units) with a ceiling value of $1,481.18. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive process. The order is scheduled for completion by December 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,876.52 to AmerisourceBergen Drug Corp for the supply of Qsymia 7.5 mg-46 mg capsules (30-count units), a prescription medication used in weight management treatment. The contract, which was competitively awarded with no set-aside designation, was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, utilizing...
- The Defense Logistics Agency awarded a delivery order valued at $10,555.98 to AmerisourceBergen Drug Corp for the supply of Qsymia 15 mg-92 mg capsules (30-count packaging) under a firm fixed-price contract. The award, issued on October 27, 2025, with an ultimate completion date of October 28, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,216.73 to AmerisourceBergen Drug Corp for the supply of Qsymia 7.5 mg-46 mg capsules (30-count) on January 12, 2026, with completion expected by January 13, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Qsymia is a prescription weight-loss medication combining phentermine and topiramate, used in...
- The Defense Logistics Agency awarded a $1,810.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Qsymia 11.25 mg-69 mg capsules (30-count), a prescription weight management medication. The order was competitively awarded with no set-aside designation and is scheduled for completion by August 18, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 8, 2025, for supply of Qsymia 3.75 mg-23 mg capsules in a 30-count package. This is a firm fixed-price delivery order with a ceiling value of $1,271.45 and an ultimate completion date of December 9, 2025. The contract was competitively awarded with no set-aside designation. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,646.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Qsymia 7.5 mg-46 mg capsules (30-count) under contract 4569035131. The delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-set-aside, competitively awarded procurement. Performance will be executed from the vendor's Conshohocken, Pennsylvania location, which serves as the company's corporate office and...
- The Defense Logistics Agency awarded a delivery order valued at $1,071.43 to AmerisourceBergen Drug Corp for Qsymia 3.75 mg-23 mg capsules (30-count units), with performance in Conshohocken, Pennsylvania and completion by September 23, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Qsymia 11.25 mg-69 mg capsules (30-count) valued at $1,614.09, with an ultimate completion date of September 26, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing...
- The Defense Logistics Agency awarded a delivery order valued at $1,413.00 to AmerisourceBergen Drug Corp for Qsymia 15mg-92mg in a 30-count supply, with an ultimate completion date of November 26, 2025. This non-competitive, firm fixed-price delivery order was issued on November 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA....
- SPE2DR25D3401Indefinite Delivery Contract
- SPE2DR25D3401-SPE2DR26FL1CBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,500.96 to AmerisourceBergen Drug Corp for the supply of Qsymia 7.5 mg–46 mg capsules (30-count units) on January 21, 2026, with an ultimate completion date of January 22, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order under the parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle that extends through December 31, 2031 and serves as the primary mechanism for delivering comprehensive pharmaceutical and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, continues to fulfill critical medical procurement needs for federal military and veteran healthcare systems through this delivery order and its portfolio of federal contracts. The supply of Qsymia, an obesity management medication, reflects the company's established capability to deliver specialty pharmaceuticals across multiple therapeutic domains to the Department of Defense and affiliated healthcare institutions. The competitive award and firm fixed-price structure are consistent with AmerisourceBergen Drug Corp's track record of meeting federal procurement requirements through open competition on the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 1/20/26 |